SERPINA4 antibody (AA 161-220)
Quick Overview for SERPINA4 antibody (AA 161-220) (ABIN714731)
Target
See all SERPINA4 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 161-220
-
Cross-Reactivity
- Mouse
-
Predicted Reactivity
- Human,Rat
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human KLST/Kallistatin (161-220aa)
-
Isotype
- IgG
-
-
-
-
Application Notes
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Expiry Date
- 12 months
-
-
-
: "Polymorphisms at the F12 and KLKB1 loci have significant trait association with activation of the renin-angiotensin system." in: BMC medical genetics, Vol. 17, pp. 21, (2016) (PubMed).
-
-
- SERPINA4 (serpin Peptidase Inhibitor, Clade A (Alpha-1 Antiproteinase, Antitrypsin), Member 4 (SERPINA4))
-
Alternative Name
- KLST
-
Background
-
Synonyms: Serpin peptidase inhibitor clade A member 4, Kallikrein binding protein, Kallikrein inhibitor, Protease inhibitor 4, Serpin A4, KAL, Kallikrein binding protein, Kallikrein inhibitor, KBP, KLST, KST, MGC108582, PI4, Protease inhibitor 4, Serpin A4, Serpin peptidase inhibitor clade A member 4, SERPINA4, KAIN_HUMAN.
Background: Kallistatin is a serine proteinase inhibitor which binds to tissue kallikrein and inhibits its amidolytic and kininogenase activity. Inhibition is achieved by formation of an equimolar, heat- and SDS-stable complex between the inhibitor and the enzyme, and generation of a small C-terminal fragment of the inhibitor due to cleavage at the reactive site by tissue kallikrein. Heparin blocks kallistatin's complex formation with tissue kallikrein and abolishes its inhibitory effect on tissue kallikrein's activity.
-
Gene ID
- 5267
Target
-